# EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

> **NCT00087191** · NA · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (actual)

## Conditions studied

- Advanced Adult Primary Liver Cancer
- Carcinoma of the Appendix
- Fallopian Tube Cancer
- Gastrointestinal Stromal Tumor
- Localized Extrahepatic Bile Duct Cancer
- Localized Gallbladder Cancer
- Localized Gastrointestinal Carcinoid Tumor
- Localized Resectable Adult Primary Liver Cancer
- Localized Unresectable Adult Primary Liver Cancer
- Metastatic Gastrointestinal Carcinoid Tumor
- Ovarian Sarcoma
- Ovarian Stromal Cancer
- Primary Peritoneal Cavity Cancer
- Recurrent Adult Primary Liver Cancer
- Recurrent Adult Soft Tissue Sarcoma
- Recurrent Colon Cancer
- Recurrent Extrahepatic Bile Duct Cancer
- Recurrent Gallbladder Cancer
- Recurrent Gastric Cancer
- Recurrent Gastrointestinal Carcinoid Tumor
- Recurrent Non-small Cell Lung Cancer
- Recurrent Ovarian Epithelial Cancer
- Recurrent Ovarian Germ Cell Tumor
- Recurrent Pancreatic Cancer
- Recurrent Rectal Cancer
- Recurrent Small Intestine Cancer
- Recurrent Uterine Sarcoma
- Regional Gastrointestinal Carcinoid Tumor
- Small Intestine Adenocarcinoma
- Small Intestine Leiomyosarcoma
- Small Intestine Lymphoma
- Stage 0 Non-small Cell Lung Cancer
- Stage I Adult Soft Tissue Sarcoma
- Stage I Colon Cancer
- Stage I Gastric Cancer
- Stage I Non-small Cell Lung Cancer
- Stage I Ovarian Epithelial Cancer
- Stage I Ovarian Germ Cell Tumor
- Stage I Pancreatic Cancer
- Stage I Rectal Cancer
- Stage I Uterine Sarcoma
- Stage II Adult Soft Tissue Sarcoma
- Stage II Colon Cancer
- Stage II Gastric Cancer
- Stage II Non-small Cell Lung Cancer
- Stage II Ovarian Epithelial Cancer
- Stage II Ovarian Germ Cell Tumor
- Stage II Pancreatic Cancer
- Stage II Rectal Cancer
- Stage II Uterine Sarcoma
- Stage III Adult Soft Tissue Sarcoma
- Stage III Colon Cancer
- Stage III Gastric Cancer
- Stage III Ovarian Epithelial Cancer
- Stage III Ovarian Germ Cell Tumor
- Stage III Pancreatic Cancer
- Stage III Rectal Cancer
- Stage III Uterine Sarcoma
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer
- Stage IV Adult Soft Tissue Sarcoma
- Stage IV Colon Cancer
- Stage IV Gastric Cancer
- Stage IV Non-small Cell Lung Cancer
- Stage IV Ovarian Epithelial Cancer
- Stage IV Ovarian Germ Cell Tumor
- Stage IV Pancreatic Cancer
- Stage IV Rectal Cancer
- Stage IV Uterine Sarcoma
- Unresectable Extrahepatic Bile Duct Cancer
- Unresectable Gallbladder Cancer

## Interventions

- **DRUG:** EF5
- **DRUG:** motexafin lutetium
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00087191
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-05
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Administratively complete.
- **Last updated:** 2013-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00087191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00087191, "EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00087191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*